Results 141 to 150 of about 82,196 (246)

Buprenorphine discontinuation and utilization of psychosocial services: a national study in the Veterans Health Administration. [PDF]

Addict Sci Clin Pract
Cleary EN, Rollins AL, McGuire AB, Myers LJ, Quinn PD.   +4 more
europepmc   +1 more source

Buprenorphine

, 1991
Richard Ginsburg, Maurice Lippmann
openalex   +1 more source

Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity. [PDF]

Trials
Mansoori A, Bazrafshan A, Ahmadi J, Mosavat SH.   +3 more
europepmc   +1 more source

How the Misunderstanding that Heroin Addiction Is a Choice and the Stigma Surrounding Medication-Assisted Treatment Leads to More Overdose Deaths

, 2018
Heroin is an opioid that commonly appears as white or brown powder. Eventually a person can become physically dependent on heroin, meaning the body begins to expect the drug.
Drew, Margaret M.
core  

Preparation of Buprenorphine Sublingual Tablets and Clinical Effects.

, 1994
Michiteru Ohtani, Hajime Kotaki, Fuminori Shibuya, Kenji Nishitateno, Yasufumi Sawada, Tatsuji Iga   +5 more
openalex   +2 more sources

Plasma concentrations of buprenorphine 24 to 72 hours after dosing

, 1999
Marek C. Chawarski, Richard S. Schottenfeld, PatrickG O’Connor, Juliana Pakes   +3 more
openalex   +1 more source

Lack of Effect of Single High Doses of Buprenorphine on Arterial Blood Gases in the Rat [PDF]

, 2001
Papa Guèye, Stephen W. Borron, Patricia Risède, Claíre Moníer, F Buneaux, M Debray, Frédéric J. Baud   +6 more
openalex   +1 more source

Barriers to Buprenorphine Treatment Among People Experiencing Homelessness: A Qualitative Study from the Provider Perspective. [PDF]

J Urban Health
Masson CL, Knight KR, Levine EA, Spillane JA, Liang YCA, Suen LW, Chen MM, Zevin B, Schwartz RP, Coffin PO, Sorensen JL.   +10 more
europepmc   +1 more source

Less Driving Impairment on Buprenorphine than Methadone in Drug-Dependent Patients? [PDF]

, 2001
Michael Soyka, Michael Horak, S. Dittert, Sabine Kagerer   +3 more
openalex   +1 more source

The impact of psychostimulant use on office based buprenorphine treatment retention. [PDF]

Harm Reduct J
Edgerton R, Rebeiro P, MacMaster S, Bell L, Patel P, Ginn L, Beach K, Shah V, Cooper RL.   +8 more
europepmc   +1 more source